PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.
about
PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@en
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@nl
type
label
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@en
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@nl
prefLabel
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@en
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@nl
P2093
P2860
P50
P356
P1433
P1476
PAX3d mRNA over 2.76 copies/µL ...... us malignant melanoma relapse.
@en
P2093
Cappellini Antonini Gian Carlo
Chiara Autilio
Elisa De Paolis
Enrico Di Stasio
Krizia Pocino
Maria Michela Lavieri
P2860
P304
85479-85491
P356
10.18632/ONCOTARGET.20177
P407
P577
2017-08-11T00:00:00Z